Label: DOCUSATE SODIUM capsule

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 12, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each softgel)

    Docusate Sodium 100 mg

  • Purpose

    Stool softener

  • Uses

    • relieves occasional constipation (irregularity) 
    • generally produces bowel movement in 12 to 72 hours
  • Warnings

    Do not use if you are presently taking mineral oil, unless directed by a doctor

    Ask a doctor before use if you have

    • stomach pain
    • nausea or vomiting
    • noticed a sudden change in bowel habits that lasts over 2 weeks

    Stop use and ask a doctor if

    • you have rectal bleeding or fail to have bowel movement after use of a laxative. These could be signs of a serious condition.
    • you need to use a stool softener laxative for more than 1 week

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

  • Directions

    • Take only by mouth. Doses may be taken as a single daily dose or in divided doses.
    adults and children 12 years and over                take 1-3 softgels daily
    children 2 to under 12 years of agetake 1 softgel daily
    children under 2 years of ageask a doctor

  • Other information

    • Tamper Evident:Do not use if seal is broken or missing from bottle
    • each softgel contains: sodium 6 mg
    • VERY LOW SODIUM
    • store at 25 oC (77 oF); excursions permitted between 15 o-30 oC (59 o-86 oF).

    keep tightly closed.

  • Inactive ingredients

    D&C Red #33, edible ink, FD&C Red #40, FD&C Yellow #6, gelatin, glycerin, polyethylene glycol, purified water, sorbitol special 

  • Questions?

    Adverse drug event call:(866) 562-2756 Mon-Fri 8 AM to 4 PM

  • PRINCIPAL DISPLAY PANEL

    Docusate

    Sodium

    55289493 Label

  • INGREDIENTS AND APPEARANCE
    DOCUSATE SODIUM 
    docusate sodium capsule
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55289-493(NDC:16103-399)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM100 mg
    Inactive Ingredients
    Ingredient NameStrength
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    WATER (UNII: 059QF0KO0R)  
    SORBITOL (UNII: 506T60A25R)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
    Product Characteristics
    Colorred (Two-toned- white and clear red) Scoreno score
    ShapeOVALSize12mm
    FlavorImprint Code SCU2
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:55289-493-1212 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product04/21/2021
    2NDC:55289-493-1414 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/12/2018
    3NDC:55289-493-3030 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/12/2018
    4NDC:55289-493-6060 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/12/2018
    5NDC:55289-493-9090 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/12/2018
    6NDC:55289-493-93180 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product03/28/2023
    7NDC:55289-493-01100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/18/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00703/01/2016
    Labeler - PD-Rx Pharmaceuticals, Inc. (156893695)
    Registrant - PD-Rx Pharmaceuticals, Inc. (156893695)
    Establishment
    NameAddressID/FEIBusiness Operations
    PD-Rx Pharmaceuticals, Inc.156893695repack(55289-493)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!